ECHA

Nanotechnology for Parkinson’s treatment: a novel encapsulation approach allows efficient dopamine delivery to the brain: 14 September 2021; Read the latest Nanopinion guest column from Dr. Daniel Ruiz-Molina about a novel nanotechnological encapsulation approach to deliver dopamine to the brain. The delivery could be used to treat Parkinson’s disease, which is caused by a deficit of dopamine due to the death of the neurons responsible for its production.

15 July 2021 ECHA Nanomaterials Expert Group (NMEG)

Read out latest Nanopinion guest column from Frank Le Curieux, Scientific Area Leader for Genotoxicity at the European Chemicals Agency (ECHA). Our author presents the ECHA Nanomaterials Expert Group (NMEG) by writing about its creation and history, its organisation, its main tasks and its future after 2021.

Nanomaterials and health

Are substances in nanoforms more dangerous than they are in their normal size? Some are and some are not. Just like any other chemical substance, nanomaterials have to be assessed separately.

Fighting cancer using nanotechnology

Nanomaterials are not only used in consumer products, but also in new and innovative medical treatments. Research has shown that nanoparticles can be used to damage and even destroy cancer cells from within.